{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["666766aa-c0fe-4e18-a2cb-5ea55b8a464d", "Q1", 401103172, "CARLIN COMMUNICATIONS", 198070, "BAVARIAN NORDIC A/S", 2014, "first_quarter", "2014-04-16T20:26:11.990000-04:00", 21000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/666766aa-c0fe-4e18-a2cb-5ea55b8a464d/\", \"filing_uuid\": \"666766aa-c0fe-4e18-a2cb-5ea55b8a464d\", \"filing_type\": \"Q1\", \"filing_type_display\": \"1st Quarter - Report\", \"filing_year\": 2014, \"filing_period\": \"first_quarter\", \"filing_period_display\": \"1st Quarter (Jan 1 - Mar 31)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/666766aa-c0fe-4e18-a2cb-5ea55b8a464d/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"21000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Ellen P. Carlin\", \"dt_posted\": \"2014-04-16T20:26:11.990000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"3430 Connecticut Avenue NW, #4938\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"Washington\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20008\", \"registrant\": {\"id\": 401103172, \"url\": \"https://lda.senate.gov/api/v1/registrants/401103172/\", \"house_registrant_id\": 42470, \"name\": \"CARLIN COMMUNICATIONS\", \"description\": \"Science policy writing and consulting\", \"address_1\": \"3430 Connecticut Avenue NW, #4938\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20008\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"ELLEN P. CARLIN\", \"contact_telephone\": \"+1 202-669-7830\", \"dt_updated\": \"2022-04-06T16:07:43.246442-04:00\"}, \"client\": {\"id\": 198070, \"url\": \"https://lda.senate.gov/api/v1/clients/198070/\", \"client_id\": 12, \"name\": \"BAVARIAN NORDIC A/S\", \"general_description\": \"Biotechnology\", \"client_government_entity\": false, \"client_self_select\": false, \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": null, \"ppb_state_display\": null, \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2013-11-04\"}, \"lobbying_activities\": [{\"general_issue_code\": \"HOM\", \"general_issue_code_display\": \"Homeland Security\", \"description\": \"FY15 appropriations for biodefense aspects of homeland security, specifically BARDA, BioShield, Strategic National Stockpile, and pandemic influenza accounts. General educational meetings on smallpox preparedness.\", \"foreign_entity_issues\": \"Bavarian Nordic A/S manufactures smallpox vaccine for Strategic National Stockpile.\", \"lobbyists\": [{\"lobbyist\": {\"id\": 59609, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ELLEN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"CARLIN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MED\", \"general_issue_code_display\": \"Medical/Disease Research/Clinical Labs\", \"description\": \"FY15 appropriations for biodefense, specifically BARDA, BioShield, Strategic National Stockpile, and pandemic influenza accounts. General educational meetings on smallpox preparedness and medical countermeasures.\", \"foreign_entity_issues\": \"Bavarian Nordic A/S manufactures smallpox vaccine for Strategic National Stockpile.\", \"lobbyists\": [{\"lobbyist\": {\"id\": 59609, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ELLEN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"CARLIN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}", "DC", "US", 42470, "DC", null, "US", "US", "Biotechnology", 0, 0, null, null, null, null]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json", "registrant_state", "registrant_country", "registrant_house_id", "client_state", "client_ppb_state", "client_country", "client_ppb_country", "client_general_description", "client_government_entity", "affiliated_org_count", "client_entity_id", "client_government_unit_id", "client_match_method", "client_match_confidence"], "primary_keys": ["filing_uuid"], "primary_key_values": ["666766aa-c0fe-4e18-a2cb-5ea55b8a464d"], "units": {}, "query_ms": 0.5545460153371096, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}